What's Going On With Hims & Hers Health Stock On Wednesday? [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
To address the issue, the company launched a GLP-1 Supply Tracker, allowing individuals to report their experiences and advocate for improved access to essential medication. The move comes despite last week's update when the FDA revised its shortage list to note that the .25 mg starter dose of semaglutide-based obesity med Wegovy is now available in the U.S Last month, the FDA removed Eli Lilly And Co's (NYSE: LLY) tirzepatide from its shortage list Since September, Hims & Hers has been collecting data on these access issues. Nearly 80,000 individuals on their platform reported difficulties in obtaining branded GLP-1s, with notable challenges in states with high obesity rates. Also Read: Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages In Texas, for example, nearly 5,000 customers shared their struggles in acquiring the needed treatment. The company has been in dialogue with state and federal agencies,
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Hims & Hers Health, Inc. (NYSE: HIMS) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $42.00 price target on the stock.MarketBeat
- Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]Yahoo! Finance
- HIMS Stock Surges 43% in a Month: Will the Uptrend Continue Further? [Yahoo! Finance]Yahoo! Finance
- The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About WeightBusiness Wire
- Hims & Hers Named to Inc.'s 2024 Best in Business List in Health Products Category [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 11/4/24 - Beat
HIMS
Sec Filings
- 12/20/24 - Form 144
- 12/19/24 - Form 144
- 12/17/24 - Form 4/A
- HIMS's page on the SEC website